Table 1.
Comparison of ex vivo and in vivo arterial paclitaxel levels following keratose-paclitaxel DCB delivery.
| Testing Model | Paclitaxel (ng/mg) | p-value |
|---|---|---|
| Ex vivo | 43.60±14.8 | 0.71 |
| In vivo | 56.60±66.4 | |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.